ARCT - MCAP CO - Arcturus Therapeutics

Arcturus Therapeutics (ARCT) develops cutting-edge mRNA therapeutics and vaccines, utilizing its unique LUNAR delivery system to reduce drug dosages. The business relies on collaboration with government agencies and private entities, expanding its reach through self-amplifying RNA. Current market capitalization stands at 0.39. This chart of current quotes on GURU.Markets highlights volatility driven by the complexity of clinical trials and financial risks.

Market capitalization represents the aggregate value of all a business's shares, reflecting the market's valuation of a company's fundamental value through the product of the current share price and the number of issued securities. By analyzing the current capitalization volume of Arcturus Therapeutics (ARCT), an investor can observe the market's reaction to financial reports and strategic payments from global partners that support the value of the company's biopharmaceutical developments.